Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Approximately 5–10% of all breast and ovarian cancers are due to genetic predisposition.1 Germline mutations in two major susceptibility genes, BRCA1 and BRCA2 , explain most of the hereditary ovarian cancer cases, but worldwide have been observed only in a fraction of the breast cancer families; in Finland, about 20%.2–4 A small portion of the remaining cases, perhaps 1–2%, appears to be caused by germline mutations in other cancer susceptibility genes such as TP53 , PTEN , AR , and ATM .5 Recently, moderate or low penetrance germline mutations such as 1100delC of CHK2 have also been implicated,6 suggesting that in many cases the phenotypic expression of the disease is accounted for by the combined effect of multiple but more subtle mutations in different target genes.5,7 Despite all these discoveries, many breast cancer families, especially those with fewer than four cases and/or with later disease onset, have cancers due to mutations in still unknown genes. As the protein products of the genes so far indicated are central players in the pathways involved in cell cycle checkpoint functions and in the sensing, transduction, and repair of DNA lesions,5 other similarly acting genes may represent new potential candidates for breast and/or ovarian cancer susceptibility. The Mre11 complex, composed of the proteins MRE11, NBS1, and RAD50, is a vital component in the DNA damage response and is at least partially responsible for connecting DNA damage detection to DNA repair and cell cycle checkpoint functions. The early association of the complex with damaged DNA suggests its involvement in sensing DNA double strand breaks (DSBs). In eukaryotes, DSB repair is handled by two different pathways, homologous recombination (HR) and non-homologous end joining (NHEJ), and the initial step in both is the recognition and signalling of the damage …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., Hays, L., Morgan, W. F., & Petrini, J. H. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81175-7 · Cited by 1,226
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome
Varon, R., Vissinga, C., Platzer, M., Cerosaletti, K. M., Chrzanowska, K. H., Saar, K., Beckmann, G., Seemanová, E., Cooper, P. R., Nowak, N. J., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81174-5 · Cited by 1,079
The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling
D'Amours, D., & Jackson, S. P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm805 · Cited by 874
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
Dolganov, G. M., Maser, R. S., Novikov, A., Tosto, L., Chong, S., Bressan, D. A., & Petrini, J. H. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4832 · Cited by 224
Cancer predisposition and hematopoietic failure in Rad50 S/S mice
Bender, C. F., Sikes, M. L., Sullivan, R., Huye, L. E., Le Beau, M. M., Roth, D. B., Mirzoeva, O. K., Oltz, E. M., & Petrini, J. H. J. (2002) · Genes & Development · doi:10.1101/gad.1007902 · Cited by 213
Chk2 Activation Dependence on Nbs1 after DNA Damage
Buscemi, G., Savio, C., Zannini, L., Miccichè, F., Masnada, D., Nakanishi, M., Tauchi, H., Komatsu, K., Mizutani, S., Khanna, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5214-5222.2001 · Cited by 201
Tauchi, H., Kobayashi, J., Morishima, K.-I., Matsuura, S., Nakamura, A., Shiraishi, T., Ito, E., Masnada, D., Delia, D., & Komatsu, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000578200 · Cited by 156
Cited by
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
DNA repair dysregulation from cancer driver to therapeutic target
Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051
Hereditary Breast Cancer: The Era of New Susceptibility Genes
Apostolou, P., & Fostira, F. (2013) · BioMed Research International · doi:10.1155/2013/747318 · Cited by 351
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability
Heikkinen, K. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi360 · Cited by 208
Self-citationKaymaz, Y., Oduor, C. I., Yu, H., Otieno, J. A., Ong'echa, J. M., Moormann, A. M., & Bailey, J. A. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0305 · Cited by 120
Metadata
- Authors
- Heikkinen, K., Karppinen, S.-M., Soini, Y., Mäkinen, M., & Winqvist, R.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2003-12
- Volume
- 40
- Issue
- 12
- Pages
- e131-e131
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2166752171
- Cited by
- 107
- References
- 13
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility. https://app.cochat.ai/papers/10.1136/jmg.40.12.e131
- The paper
- Heikkinen, K., Karppinen, S.-M., Soini, Y., Mäkinen, M., & Winqvist, R. (2003). Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility. Journal of Medical Genetics. https://doi.org/10.1136/jmg.40.12.e131
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.